INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

76,421 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
NS
Newcomb Matthew SChief Financial Officer
CHYMChime Financial, Inc.
Gift
G—
17.7K sh
May 18, 2026May 18, 2026
Page 948 of 1911
← PrevNext →
traded May 18, 2026
+0d
SEC Form 4

Evidence

8
NS
Newcomb Matthew SChief Financial Officer
CHYMChime Financial, Inc.
Gift
G—
17.7K sh
May 18, 2026May 18, 2026
traded May 18, 2026
+0dSEC Form 4

Evidence

8
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Option exercise
M$66K
8,100 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

8
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise
M$183K
14.5K sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

8
DR
Denton John RusselSee Remarks
CAICaris Life Sciences, Inc.
Tax withholding
F$92K
6,047 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

8
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Tax withholding
F$211K
13.9K sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

8
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Tax withholding
F$164K
9,170 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

8
KA
Kazmi Amir A.SVP - Chief Technology Officer
RALRalliant Corp
Tax withholding
F$100K
1,692 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

5
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Disposition to issuer
D—
13.8K sh
May 18, 2026May 18, 2026
traded May 18, 2026
+0dSEC Form 4

Evidence

5
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Disposition to issuer
D—
11.9K sh
May 18, 2026May 18, 2026
traded May 18, 2026
+0dSEC Form 4

Evidence

5
SM
Sever MichalCMO
NYAXNayax Ltd.
Option exercise
M—
3,437 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

5
SM
Sever MichalCMO
NYAXNayax Ltd.
Option exercise
M—
1,563 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

5
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Disposition to issuer
D—
110.0K sh
May 18, 2026May 18, 2026
traded May 18, 2026
+0dSEC Form 4

Evidence

5
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise
M—
6,601 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

5
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Disposition to issuer
D—
39.8K sh
May 18, 2026May 18, 2026
traded May 18, 2026
+0dSEC Form 4

Evidence

4
AJ
Allison JonathanChief Administrative Officer
ROOTRoot, Inc.
Open-market sale · 10b5-1 plan
SELL$90K
1,606 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC Form 4

Evidence

2
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Grant or award
A$16K
131 sh
May 14, 2026May 18, 2026
traded May 14, 2026
+4dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
May 14, 2026May 18, 2026
traded May 14, 2026
+4dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$156K
15.0K sh
May 14, 2026May 18, 2026
traded May 14, 2026
+4dSEC Form 4

Evidence

66
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Open-market sale
SELL$26.17M
2.00M sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

65
Pershing Square Capital Management, L.P.13F filer
MSFTMICROSOFT CORP
NEW
BUY$2.09B
5.65M sh
Not disclosedMay 15, 2026quarterlySEC 13F

Evidence

59
Pershing Square Capital Management, L.P.13F filer
GOOGAlphabet Inc.
TRIM
SELL$1.68B
5.85M sh
Not disclosedMay 15, 2026quarterlySEC 13F

Evidence

58
PS
Parekh Salil S.Director, CEO & Managing Director
INFYInfosys Ltd
Open-market sale
SELL$112.84M
95.8K sh
May 8, 2026May 15, 2026
traded May 8, 2026
+7dSEC Form 4

Evidence

51
WP
Warburg Pincus & Co.Director, 10% Owner
SHCSotera Health Co
Open-market sale
SELL$289.75M
19.10M sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC Form 4

Evidence

51
WP
Warburg Pincus & Co.Director, 10% Owner
SHCSotera Health Co
Open-market sale
SELL$289.75M
19.10M sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC Form 4

Evidence

50
ST
Sutton ToddVP Corporate Controller
ACLSAXCELIS TECHNOLOGIES INC
Open-market sale
SELL$422K
2,574 sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

48
AM
Allemann David MichaelDirector, Executive Officer & Co-CEO
ONONOn Holding AG
Open-market purchase
BUY$1.87M
50.9K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

48
BO
Bernhard OlivierDirector, Executive Officer
ONONOn Holding AG
Open-market purchase
BUY$1.87M
50.9K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

48
CF
Coppetti Caspar FelixDirector, Executive Officer & Co-CEO
ONONOn Holding AG
Open-market purchase
BUY$1.87M
50.9K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

47
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$7.26M
555.6K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

47
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$7.80M
555.6K sh
May 15, 2026May 15, 2026
traded May 15, 2026
+0dSEC Form 4

Evidence

46
Pershing Square Capital Management, L.P.13F filer
GOOGAlphabet Inc.
TRIM
SELL$185.74M
645.9K sh
Not disclosedMay 15, 2026quarterlySEC 13F

Evidence

45
CF
Coppetti Caspar FelixDirector, Executive Officer & Co-CEO
ONONOn Holding AG
Open-market purchase
BUY$329K
9,147 sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

45
AM
Allemann David MichaelDirector, Executive Officer & Co-CEO
ONONOn Holding AG
Open-market purchase
BUY$329K
9,144 sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

45
BO
Bernhard OlivierDirector, Executive Officer
ONONOn Holding AG
Open-market purchase
BUY$329K
9,144 sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

45
SA
Sinha AnkurChief Product and Tech Officer
RELYRemitly Global, Inc.
Open-market sale
SELL$1.17M
50.0K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

43
EJ
Emery JeffreyPresident - Global Fire Safety
PRMPerimeter Solutions, Inc.
Open-market sale
SELL$1.79M
53.5K sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC Form 4

Evidence

43
SK
Sable KyleChief Financial Officer
PRMPerimeter Solutions, Inc.
Open-market sale
SELL$1.53M
46.3K sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC Form 4

Evidence

42
MC
Mitchell William ClydePresident of AFC
KAROPENLANE, Inc.
Open-market sale
SELL$234K
6,500 sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC Form 4

Evidence

42
Pershing Square Capital Management, L.P.13F filer
AMZNAMAZON COM INC
ADD
BUY$384.08M
1.84M sh
Not disclosedMay 15, 2026quarterlySEC 13F

Evidence